全球Sunitinib蘋果酸市場：按純度、按適應症分類 - 預測 2024-2030 年

Sunitinib替尼市場規模預計2023年為1.2327億美元，2024年為1.3472億美元，預計到2030年將達到2.3713億美元，複合年成長率為9.79%。

Sunitinib酸舒尼替尼的全球市場

FPNV定位矩陣

FPNV定位矩陣對於評估Sunitinib替尼市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對Sunitinib蘋果酸市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並制定有效的策略來提高其市場競爭力。

主要企業簡介

本報告深入探討了Sunitinib舒尼替尼市場的最新關鍵發展，並介紹了主要供應商及其創新概況。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 胰臟神經內分泌腫瘤（pNET）盛行率增加
    • 可用於治療進行性pNET 的藥物選擇有限
  • 抑制因素
    • 製造Sunitinib替尼藥物所需原料成本較高
  • 機會
    • 製藥公司持續研發，探索Sunitinib替尼的新適應症與組合
    • 提高患者和醫療保健提供者對癌症治療標靶治療益處的認知
  • 任務
    • 臨床試驗期間報告的不良心血管事件
• 市場區隔分析
• 市場趨勢分析
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範

第6章Sunitinib蘋果酸市場：依純度

• >97%
• >98%
• >99%

第7章Sunitinib舒尼替尼市場：依適應症分類

• 胃腸道基質腫瘤（GIST）
• 胰臟神經內分泌腫瘤
• 腎臟細胞癌（RCC）

第8章Sunitinib舒尼替尼美洲市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太地區Sunitinib舒尼替尼市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章Sunitinib蘋果酸市場歐洲、中東和非洲

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 競爭情境分析：主要企業

第12章競爭產品組合

• 主要企業簡介
  • Aark Pharmaceuticals
  • Active Biotech AB
  • Anant Pharmaceuticals Pvt. Ltd.
  • AstraZeneca PLC
  • Beijing Lunarsun Pharmaceutical Co., Ltd.
  • Bio-Techne Corporation
  • Brawn Laboratories Ltd.
  • Hetero Labs Limited
  • Hikma Pharmaceuticals PLC
  • JEIL PHARMACEUTICAL CO.,LTD.
  • Manus Aktteva Biopharma LLP
  • Medichem SA
  • Medzeel Lifescience
  • Nanjing First Pharmaceutical Co. Ltd,
  • Natco Pharma Limited
  • Pfizer Inc.
  • Shilpa Medicare Limited
  • Sichuan Xieli Pharmaceutical Co., Ltd.
  • Synthland Limited
  • Taj Pharma India Limited
  • TargetMol Chemicals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vivan Life Science
• 主要產品系列

第13章附錄

• 討論指南
• 關於許可證和定價

[181 Pages Report] The Sunitinib Malate Market size was estimated at USD 123.27 million in 2023 and expected to reach USD 134.72 million in 2024, at a CAGR 9.79% to reach USD 237.13 million by 2030.

Global Sunitinib Malate Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Sunitinib Malate Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Sunitinib Malate Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Sunitinib Malate Market, highlighting leading vendors and their innovative profiles. These include Aark Pharmaceuticals, Active Biotech AB, Anant Pharmaceuticals Pvt. Ltd., AstraZeneca PLC, Beijing Lunarsun Pharmaceutical Co., Ltd., Bio-Techne Corporation, Brawn Laboratories Ltd., Hetero Labs Limited, Hikma Pharmaceuticals PLC, JEIL PHARMACEUTICAL CO.,LTD., Manus Aktteva Biopharma LLP, Medichem S.A., Medzeel Lifescience, Nanjing First Pharmaceutical Co. Ltd,, Natco Pharma Limited, Pfizer Inc., Shilpa Medicare Limited, Sichuan Xieli Pharmaceutical Co., Ltd., Synthland Limited, Taj Pharma India Limited, TargetMol Chemicals Inc., Teva Pharmaceutical Industries Ltd., and Vivan Life Science.

Market Segmentation & Coverage

This research report categorizes the Sunitinib Malate Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Purity
  • >97%
  • >98%
  • >99%
• Indication
  • Gastrointestinal Stromal Tumors (GISTs)
  • Pancreatic Neuroendocrine Tumors
  • Renal Cell Carcinoma (RCC)

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

• Market Penetration: It presents comprehensive information on the market provided by key players.
• Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
• Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
• Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
• Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

• What is the market size and forecast of the Sunitinib Malate Market?
• Which products, segments, applications, and areas should one consider investing in over the forecast period in the Sunitinib Malate Market?
• What are the technology trends and regulatory frameworks in the Sunitinib Malate Market?
• What is the market share of the leading vendors in the Sunitinib Malate Market?
• Which modes and strategic moves are suitable for entering the Sunitinib Malate Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Sunitinib Malate Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in prevalence of pancreatic neuroendocrine tumors (pNET)
    • 5.1.1.2. Availability of limited drug options for treatment of advanced pNET
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of raw materials for manufacturing of sunitinib malate drug
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development by pharmaceutical companies to explore new indications and combinations for sunitinib malate
    • 5.1.3.2. Increasing awareness about the benefits of targeted therapies in cancer treatment among patients and healthcare providers
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse cardiovascular events reported during clinical trials
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Sunitinib Malate Market, by Purity

• 6.1. Introduction
• 6.2. >97%
• 6.3. >98%
• 6.4. >99%

7. Sunitinib Malate Market, by Indication

• 7.1. Introduction
• 7.2. Gastrointestinal Stromal Tumors (GISTs)
• 7.3. Pancreatic Neuroendocrine Tumors
• 7.4. Renal Cell Carcinoma (RCC)

8. Americas Sunitinib Malate Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Sunitinib Malate Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Sunitinib Malate Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Aark Pharmaceuticals
  • 12.1.2. Active Biotech AB
  • 12.1.3. Anant Pharmaceuticals Pvt. Ltd.
  • 12.1.4. AstraZeneca PLC
  • 12.1.5. Beijing Lunarsun Pharmaceutical Co., Ltd.
  • 12.1.6. Bio-Techne Corporation
  • 12.1.7. Brawn Laboratories Ltd.
  • 12.1.8. Hetero Labs Limited
  • 12.1.9. Hikma Pharmaceuticals PLC
  • 12.1.10. JEIL PHARMACEUTICAL CO.,LTD.
  • 12.1.11. Manus Aktteva Biopharma LLP
  • 12.1.12. Medichem S.A.
  • 12.1.13. Medzeel Lifescience
  • 12.1.14. Nanjing First Pharmaceutical Co. Ltd,
  • 12.1.15. Natco Pharma Limited
  • 12.1.16. Pfizer Inc.
  • 12.1.17. Shilpa Medicare Limited
  • 12.1.18. Sichuan Xieli Pharmaceutical Co., Ltd.
  • 12.1.19. Synthland Limited
  • 12.1.20. Taj Pharma India Limited
  • 12.1.21. TargetMol Chemicals Inc.
  • 12.1.22. Teva Pharmaceutical Industries Ltd.
  • 12.1.23. Vivan Life Science
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. SUNITINIB MALATE MARKET RESEARCH PROCESS
• FIGURE 2. SUNITINIB MALATE MARKET SIZE, 2023 VS 2030
• FIGURE 3. SUNITINIB MALATE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. SUNITINIB MALATE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. SUNITINIB MALATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. SUNITINIB MALATE MARKET DYNAMICS
• FIGURE 7. SUNITINIB MALATE MARKET SIZE, BY PURITY, 2023 VS 2030 (%)
• FIGURE 8. SUNITINIB MALATE MARKET SIZE, BY PURITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 10. SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. SUNITINIB MALATE MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. SUNITINIB MALATE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. SUNITINIB MALATE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. SUNITINIB MALATE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SUNITINIB MALATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 6. SUNITINIB MALATE MARKET SIZE, BY >97%, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. SUNITINIB MALATE MARKET SIZE, BY >98%, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. SUNITINIB MALATE MARKET SIZE, BY >99%, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 10. SUNITINIB MALATE MARKET SIZE, BY GASTROINTESTINAL STROMAL TUMORS (GISTS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. SUNITINIB MALATE MARKET SIZE, BY PANCREATIC NEUROENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. SUNITINIB MALATE MARKET SIZE, BY RENAL CELL CARCINOMA (RCC), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 20. CANADA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 21. CANADA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. CHINA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 33. CHINA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 35. INDIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. ITALY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 70. ITALY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. POLAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 78. POLAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. QATAR SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 80. QATAR SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. SUNITINIB MALATE MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 100. SUNITINIB MALATE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. SUNITINIB MALATE MARKET LICENSE & PRICING